{"id":"https://openalex.org/W7223071607","doi":"https://doi.org/10.3389/fneur.2026.1951721","title":"Rehmannioside A alleviates oxidative stress and restores dopaminergic function via the PI3K/Akt pathway in a rotenone-induced Parkinson\u2019s disease model","display_name":"Rehmannioside A alleviates oxidative stress and restores dopaminergic function via the PI3K/Akt pathway in a rotenone-induced Parkinson\u2019s disease model","publication_year":2026,"publication_date":"2026-10-20","ids":{"openalex":"https://openalex.org/W7223071607","doi":"https://doi.org/10.3389/fneur.2026.1951721","pmid":"https://pubmed.ncbi.nlm.nih.gov/42978757","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13727548"},"language":"en","primary_location":{"id":"doi:10.3389/fneur.2026.1951721","doi":"https://doi.org/10.3389/fneur.2026.1951721","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1951721","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1951721/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1951721/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159147261","display_name":"Yanqi He","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I899859998","display_name":"Qiqihar Medical University","ror":"https://ror.org/01kzgyz42","country_code":"CN","type":"education","lineage":["https://openalex.org/I899859998"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yanqi He","raw_affiliation_strings":["Mental and Health College, Qiqihar Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mental and Health College, Qiqihar Medical University","institution_ids":["https://openalex.org/I899859998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5159147261"],"corresponding_institution_ids":["https://openalex.org/I899859998"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.79400532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1951721","last_page":"1951721"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rotenone-induced-neurotoxicity","display_name":"rotenone-induced neurotoxicity","score":0.949999988079071},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.8420000076293945},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9800000190734863},{"id":"https://openalex.org/keywords/dopaminergic-neurons","display_name":"dopaminergic neurons","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tyrosine-hydroxylase","display_name":"tyrosine hydroxylase","score":0.9800000190734863},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.878000020980835},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":0.8320000171661377},{"id":"https://openalex.org/keywords/striatal-dopamine","display_name":"striatal dopamine","score":0.8069999814033508},{"id":"https://openalex.org/keywords/pc12-cells","display_name":"PC12 cells","score":0.8809999823570251},{"id":"https://openalex.org/keywords/motor-impairment","display_name":"motor impairment","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.840499997138977},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.8314999938011169},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.7139999866485596},{"id":"https://openalex.org/C159167319","wikidata":"https://www.wikidata.org/wiki/Q420766","display_name":"Tyrosine hydroxylase","level":3,"score":0.6851999759674072},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.6337000131607056},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.579800009727478},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5753999948501587},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.4991999864578247},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.4982999861240387},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.49779999256134033},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.47350001335144043},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41690000891685486},{"id":"https://openalex.org/C2776912716","wikidata":"https://www.wikidata.org/wiki/Q4042503","display_name":"LY294002","level":4,"score":0.3962000012397766},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.38440001010894775},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3840000033378601},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.38350000977516174},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37529999017715454},{"id":"https://openalex.org/C57600042","wikidata":"https://www.wikidata.org/wiki/Q227564","display_name":"Oxidative phosphorylation","level":2,"score":0.33340001106262207},{"id":"https://openalex.org/C2778401633","wikidata":"https://www.wikidata.org/wiki/Q418661","display_name":"Malondialdehyde","level":3,"score":0.33320000767707825},{"id":"https://openalex.org/C85265743","wikidata":"https://www.wikidata.org/wiki/Q885458","display_name":"Blot","level":3,"score":0.33009999990463257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.325300008058548},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.3061999976634979},{"id":"https://openalex.org/C2777477808","wikidata":"https://www.wikidata.org/wiki/Q407595","display_name":"Metabolite","level":2,"score":0.2987000048160553},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.2955000102519989},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.2865000069141388},{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.28459998965263367},{"id":"https://openalex.org/C2776165026","wikidata":"https://www.wikidata.org/wiki/Q188017","display_name":"Tyrosine","level":2,"score":0.2833000123500824},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.2766000032424927},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.27649998664855957},{"id":"https://openalex.org/C2777542381","wikidata":"https://www.wikidata.org/wiki/Q502961","display_name":"Astrocyte","level":3,"score":0.2759999930858612},{"id":"https://openalex.org/C2777288102","wikidata":"https://www.wikidata.org/wiki/Q780181","display_name":"Oxidopamine","level":5,"score":0.26440000534057617},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.2599000036716461},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.25940001010894775},{"id":"https://openalex.org/C2780369685","wikidata":"https://www.wikidata.org/wiki/Q5058184","display_name":"Cell damage","level":2,"score":0.2554999887943268},{"id":"https://openalex.org/C2780495277","wikidata":"https://www.wikidata.org/wiki/Q905442","display_name":"Glial fibrillary acidic protein","level":3,"score":0.25110000371932983}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004365","descriptor_name":"Drugs, Chinese Herbal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012402","descriptor_name":"Rotenone","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016716","descriptor_name":"PC12 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020734","descriptor_name":"Parkinsonian Disorders","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.3389/fneur.2026.1951721","doi":"https://doi.org/10.3389/fneur.2026.1951721","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1951721","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1951721/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},{"id":"pmid:42978757","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42978757","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in neurology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13727548","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13727548/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Neurol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:b519f727a9b24637972daaf4c81240d5","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b519f727a9b24637972daaf4c81240d5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Neurology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fneur.2026.1951721","doi":"https://doi.org/10.3389/fneur.2026.1951721","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fneur.2026.1951721","pdf_url":"https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2026.1951721/pdf","source":{"id":"https://openalex.org/S96975567","display_name":"Frontiers in Neurology","issn_l":"1664-2295","issn":["1664-2295"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Neurology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223071607.pdf","grobid_xml":"https://content.openalex.org/works/W7223071607.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W2027593826","https://openalex.org/W2036863248","https://openalex.org/W2055665256","https://openalex.org/W2756232480","https://openalex.org/W2907005015","https://openalex.org/W2979236832","https://openalex.org/W2995204555","https://openalex.org/W3006012411","https://openalex.org/W3006508170","https://openalex.org/W3006857739","https://openalex.org/W3021920415","https://openalex.org/W3047352432","https://openalex.org/W3105115899","https://openalex.org/W3115964749","https://openalex.org/W3122720451","https://openalex.org/W3133808912","https://openalex.org/W3211876735","https://openalex.org/W4206481149","https://openalex.org/W4210364322","https://openalex.org/W4285086539","https://openalex.org/W4292881843","https://openalex.org/W4293105022","https://openalex.org/W4300981520","https://openalex.org/W4310058947","https://openalex.org/W4313453322","https://openalex.org/W4386935787","https://openalex.org/W4390277144","https://openalex.org/W4392715239","https://openalex.org/W4406847585","https://openalex.org/W4408256661","https://openalex.org/W4410359602","https://openalex.org/W4411056469","https://openalex.org/W4411276606","https://openalex.org/W4411721999","https://openalex.org/W4412522039","https://openalex.org/W4412881998","https://openalex.org/W4413780912","https://openalex.org/W4414078509","https://openalex.org/W4416181931","https://openalex.org/W4416608748","https://openalex.org/W4417342143","https://openalex.org/W7119188508"],"related_works":["https://openalex.org/W2384646768","https://openalex.org/W3013065729","https://openalex.org/W2510835175","https://openalex.org/W4401475139","https://openalex.org/W2024506496","https://openalex.org/W4307583510","https://openalex.org/W7166826784","https://openalex.org/W4391695973","https://openalex.org/W7223449396","https://openalex.org/W2073222816"],"abstract_inverted_index":{"Objective:":[0],"Parkinson's":[1],"disease":[2],"(PD)":[3],"is":[4],"a":[5,286],"progressive":[6],"neurodegenerative":[7],"disorder;":[8],"available":[9],"treatments":[10],"merely":[11],"relieve":[12],"symptoms,":[13],"and":[14,38,75,82,97,115,152,186,193,197,216,224,236,245,277],"no":[15],"disease-modifying":[16],"therapies":[17],"are":[18],"currently":[19],"available.":[20],"This":[21],"study":[22],"sought":[23],"to":[24,89,101,111,166],"explore":[25],"the":[26,94,119,168,174,200,221,240,270],"neuroprotective":[27,261],"effects":[28,172,251],"of":[29,61,118,137,170,208,242],"Rehmannioside":[30,258],"A":[31,44,181,212,232,259,282],"(Re":[32],"A)":[33],"in":[34,52,93,122,126,199],"rotenone-induced":[35,45,264],"PD":[36,46,265],"models":[37],"clarify":[39],"its":[40,217],"underlying":[41],"mechanisms.":[42],"Methods:":[43],"rat":[47],"model":[48],"was":[49,66,87,99,109,142,164],"established":[50],"for":[51,290],"vivo":[53],"experiments,":[54,128],"with":[55,134],"rats":[56],"administered":[57],"graded":[58],"oral":[59],"doses":[60],"Re":[62,138,180,211,231,281],"A.":[63,139],"Motor":[64],"function":[65],"assessed":[67],"via":[68,268],"behavioral":[69],"tests.":[70],"Striatal":[71],"oxidative":[72,147,191,237,275],"stress":[73,148,276],"markers":[74],"neurotransmitters":[76],"were":[77,132,150,155,252],"detected":[78],"using":[79,144],"biochemical":[80],"assays":[81],"ELISA,":[83],"respectively.":[84],"HE":[85],"staining":[86],"applied":[88],"observe":[90],"histopathological":[91],"alterations":[92],"substantia":[95,201],"nigra,":[96,202],"immunohistochemistry":[98],"used":[100,165],"visualize":[102],"tyrosine":[103],"hydroxylase":[104],"(TH)-positive":[105],"neurons.":[106,210],"Western":[107,158],"blotting":[108],"performed":[110],"measure":[112],"TH":[113,226,247],"expression":[114],"key":[116],"proteins":[117],"PI3K/Akt":[120,175,222,243,271],"pathway":[121],"brain":[123],"tissue.":[124],"For":[125],"vitro":[127],"rotenone-challenged":[129],"PC12":[130],"cells":[131],"treated":[133],"different":[135],"concentrations":[136],"Cell":[140],"viability":[141],"tested":[143],"CCK-8":[145],"assay,":[146],"indicators":[149],"quantified,":[151],"protein":[153,227],"levels":[154],"analyzed":[156],"by":[157,204,255],"blot.":[159],"The":[160],"PI3K":[161],"inhibitor":[162],"LY294002":[163],"validate":[167],"reliance":[169],"protective":[171,250],"on":[173],"pathway.":[176],"Results:":[177],"In":[178,229],"vivo,":[179],"significantly":[182],"rescued":[183],"weight":[184],"loss":[185],"motor":[187],"dysfunction,":[188],"mitigated":[189],"striatal":[190,214],"stress,":[192,238],"reduced":[194],"neuronal":[195],"injury":[196],"pyknosis":[198],"accompanied":[203],"an":[205],"increased":[206],"number":[207],"TH-positive":[209],"restored":[213],"dopamine":[215],"metabolite":[218],"levels,":[219],"activated":[220],"pathway,":[223,273],"upregulated":[225],"expression.":[228,248],"vitro,":[230],"alleviated":[233],"rotenone-triggered":[234],"cytotoxicity":[235],"reversed":[239],"suppression":[241],"signaling,":[244],"elevated":[246],"These":[249],"partially":[253],"abolished":[254],"LY294002.":[256],"Conclusion:":[257],"exerts":[260],"activity":[262],"against":[263],"lesions,":[266],"possibly":[267],"activating":[269],"signaling":[272],"suppressing":[274],"preserving":[278],"dopaminergic":[279],"function.":[280],"may":[283],"serve":[284],"as":[285],"promising":[287],"therapeutic":[288],"candidate":[289],"PD.":[291]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2026-10-21T00:00:00"}